Open AccessIn Vitro Quality Evaluation of Ciprofloxacin Tablets Marketed in Dessie, Ethiopia
Author(s) -
Haile Kassahun,
Tekleab Teka Tekelehaimanot
Publication year - 2019
Publication title -
journal of drug delivery and therapeutics
Language(s) - English
Resource type - Journals
ISSN - 2250-1177
DOI - 10.22270/jddt.v9i5-s.3119
Subject(s) - ciprofloxacin , pharmacopoeia , quality (philosophy) , traditional medicine , medicine , chemistry , antibiotics , philosophy , alternative medicine , epistemology , pathology , biochemistry
Good quality medicines are a prerequisite for a successful treatment. Post marketing surveillance is very crucial to ensure product quality and eliminating substandard products to be distributed and, consequently, ensure better patient clinical outcome. Hence, this study assesses quality of six brands of ciprofloxacin tablets marketed in Dessie, Ethiopia using in vitro quality control tests. Weight variation test, disintegration test, dissolution test and assay for the content of active ingredients was done according to United sates Pharmacopoeia, 2007. The percentage content of ciprofloxacin tablets were within the range of 90-110% and the disintegration time was found between 2.375- 6.31 minutes. In addition, ciprofloxacin tablets released more than 80% of the drug after 30 minutes. Hence, all brands of ciprofloxacin tablets met the quality control parameters as per United States Pharmacopoeial specifications.
Keywords: Ciprofloxacin; Quality; Substandard; Pharmacopoeial specifications